Artificial Intelligence-Based Analysis of Uroflowmetry Patterns in Children: a Machine Learning Perspective
Launched by MARMARA UNIVERSITY · Feb 3, 2025
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
The study included uroflowmetry tests of children aged 4-17 years who were referred to our clinic with lower urinary tract symptoms. Uroflowmetry patterns were independently interpreted by three pediatric urology experts. Discrepancies in interpretations were jointly re-evaluated by the three observers, and a consensus was reached. Voiding volume, voiding duration, and urine flow rates at 0.5-second intervals were converted into numerical data for analysis. Eighty percent of the dataset was used as training data for machine learning, while there maining 20% was reserved for testing. A total...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged between 4 and 17 years with LUTS
- • Urinate more than 50% of the expected bladder capacity on UF
- Exclusion Criteria:
- • Patients who were unable to cooperate with the voiding command
- • Had neurological disorders
- • Urinate less than 50% of the expected bladder capacity on UF
- • Under 4 years of age, and were over 18 years of age
About Marmara University
Marmara University is a distinguished academic institution located in Istanbul, Turkey, renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust infrastructure and a multidisciplinary approach, the university actively engages in the development and evaluation of new therapeutic interventions, fostering collaboration among researchers, clinicians, and industry partners. Marmara University’s focus on ethical standards and patient safety underscores its dedication to contributing valuable insights to the medical community and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported